Capricor Therapeutics met with the FDA last week for a type A meeting, during which CEO Linda Marbán aimed to explain to the ...

The FDA recommends that companies use overall survival as a primary endpoint for clinical trials where feasible. The new ...

In late May, a patient died after receiving Rocket Pharmaceuticals' investigational gene therapy for Danon disease, spurring ...

Regulations aiming to lower the cost of vital medicines will instead end up restricting access and disincentivizing R&D.

VantAI will use its machine learning capabilities to identify novel target-effector pairs that Halda can use in designing its ...

A draft copy of an upcoming MAHA report reveals a strategy in lockstep with recent HHS actions such as reviving the Task ...

With its structural changes, CSL expects to generate $500 to $550 million in annualized savings over the next three years.

Media coverage can help biopharma executives connect with, inform and inspire the public. In this column, ...

The platform strategy of using one molecule to target an underlying biological pathway to address many different diseases can ...

Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

The CDC no longer recommends COVID-19 vaccines for healthy children and healthy pregnant women, a position that has been opposed by leading medical societies.

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...